» Articles » PMID: 18781659

Screening for Social Anxiety Disorder with the Self-report Version of the Liebowitz Social Anxiety Scale

Overview
Journal Depress Anxiety
Publisher Wiley
Date 2008 Sep 11
PMID 18781659
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study examined whether the self-report version of the Liebowitz Social Anxiety Scale (LSAS-SR) could accurately identify individuals with social anxiety disorder and individuals with the generalized subtype of social anxiety disorder. Furthermore, the study sought to determine the optimal cutoffs for the LSAS-SR for identifying patients with social anxiety disorder and its generalized subtype.

Methods: Two hundred and ninety-one patients with clinician-assessed social anxiety disorder (240 with generalized social anxiety disorder) and 53 control participants who were free from current Axis-1 disorders completed the LSAS-SR.

Results: Receiver Operating Characteristic analyses revealed that the LSAS-SR performed well in identifying participants with social anxiety disorder and generalized social anxiety disorder. Consistent with Mennin et al.'s [2002: J Anxiety Disord 16:661-673] research on the clinician-administered version of the LSAS, cutoffs of 30 and 60 on the LSAS-SR provided the best balance of sensitivity and specificity for classifying participants with social anxiety and generalized social anxiety disorder, respectively.

Conclusions: The LSAS-SR may be an accurate and cost-effective way to identify and subtype patients with social anxiety disorder, which could help increase the percentage of people who receive appropriate treatment for this debilitating disorder.

Citing Articles

Electrocortical signatures of attentional bias toward subliminal and supraliminal socially negative words in social anxiety.

Gan S, Cai Y, Li W Front Psychiatry. 2025; 16:1506516.

PMID: 40018680 PMC: 11865052. DOI: 10.3389/fpsyt.2025.1506516.


Examining the Psychometric Network Structure of Social Anxiety: A Scoping Review.

Noda S, Nishiuchi M, Andreoli G, Hofmann S Clin Psychol Psychother. 2025; 32(1):e70032.

PMID: 39828329 PMC: 11743215. DOI: 10.1002/cpp.70032.


Quality of cognitive-behavioural therapy in routine psychiatric care: therapist adherence and competence, and patient outcomes for depression and anxiety disorders.

Bergvall H, Linde J, Alfonsson S, Sunnhed R, Barber J, Lundgren T BMC Psychiatry. 2024; 24(1):887.

PMID: 39633319 PMC: 11616186. DOI: 10.1186/s12888-024-06328-4.


Clinical Considerations for an Evidence-Based Assessment of Anxiety Disorders in Adults.

Steuber E, Miller M, McGuire J Psychiatr Clin North Am. 2024; 47(4):623-639.

PMID: 39505445 PMC: 11541043. DOI: 10.1016/j.psc.2024.04.009.


Biological aging analysis based on DNA methylation status for social anxiety disorder.

Noguchi N, Shirai T, Suda A, Hattori S, Miyauchi M, Okazaki S Neuropsychopharmacol Rep. 2024; 44(4):774-783.

PMID: 39403983 PMC: 11609738. DOI: 10.1002/npr2.12487.